Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. Denmark
  4. Nasdaq Copenhagen
  5. Stenocare A/S
  6. News
  7. Summary
    STENO   DK0061078425

STENOCARE A/S

(STENO)
Delayed Nasdaq Copenhagen  -  05/23 07:38:40 am EDT
10.86 DKK   -4.06%
05/19Communique from the annual general meeting of stenocare
AQ
05/16STENOCARE delivers first product batch to the Danish market
AQ
05/16Stenocare A/S Delivers First Product Batch to the Danish Market
CI
SummaryQuotesChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Stenocare to Proceed with Validation of New Medical Cannabis Oil's Effects

01/17/2022 | 03:33am EDT
share with twitter
share with LinkedIn
share with facebook


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
AURORA CANNABIS INC. -4.11% 3.73 Delayed Quote.-45.55%
AUXLY CANNABIS GROUP INC. -10.34% 0.13 Delayed Quote.-29.73%
CANOPY GROWTH CORPORATION -5.59% 7.09 Delayed Quote.-35.78%
CRONOS GROUP INC. -0.69% 4.34 Delayed Quote.-12.85%
HEXO CORP. -7.89% 0.35 Delayed Quote.-60.23%
LONDON BRENT OIL 0.79% 113.5 Delayed Quote.44.68%
ORGANIGRAM HOLDINGS INC. -4.35% 1.54 Delayed Quote.-30.63%
STENOCARE A/S -4.06% 10.86 Delayed Quote.9.48%
THE GREEN ORGANIC DUTCHMAN HOLDINGS LTD. 10.53% 0.105 Delayed Quote.10.53%
WTI 0.78% 111.066 Delayed Quote.44.84%
All news about STENOCARE A/S
05/19Communique from the annual general meeting of stenocare
AQ
05/16STENOCARE delivers first product batch to the Danish market
AQ
05/16Stenocare A/S Delivers First Product Batch to the Danish Market
CI
05/05Stenocare A/S Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
05/04Notice to Annual General Meeting in STENOCARE A/S
AQ
05/02STENOCARE is ready to start delivery of their THC oil products to Danish patients
AQ
05/02Stenocare Is Ready to Start Delivery of Their THC Oil Products to Danish Patients
CI
03/17STENOCARE A/S publishes Annual Report 2021
AQ
03/10STENOCARE INITIATES GUIDANCE : 15-20mDKK in annual revenue run rate by end of 2022
AQ
03/10Stenocare A/S Provides Revenue Guidance for the Third Quarter, Fourth Quarter, and Full..
CI
More news
Financials
Sales 2021 1,89 M 0,27 M 0,27 M
Net income 2021 -12,7 M -1,80 M -1,80 M
Net cash 2021 10,5 M 1,48 M 1,48 M
P/E ratio 2021 -9,49x
Yield 2021 -
Capitalization 129 M 18,3 M 18,3 M
EV / Sales 2020 996x
EV / Sales 2021 56,9x
Nbr of Employees -
Free-Float 59,1%
Chart STENOCARE A/S
Duration : Period :
Stenocare A/S Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends STENOCARE A/S
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Managers and Directors
Thomas Skovlund Schnegelsberg Chief Executive Officer
Peter Bugge Johansen Chief Financial Officer
Marianne Wier Non-Executive Chairman
Søren Kjær Chief Operating Officer
Jeppe Bo Petersen Independent Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
STENOCARE A/S9.48%18
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.18.06%5 776
DONG-E-E-JIAO CO.,LTD.-35.98%3 003
TASLY PHARMACEUTICAL GROUP CO., LTD-33.12%2 366
CANOPY GROWTH CORPORATION-35.78%2 202
PT INDUSTRI JAMU DAN FARMASI SIDO MUNCUL TBK10.98%1 963